Multivariate analysis identifies the estradiol level at ovulation triggering as an independent predictor of the first trimester pregnancy-associated plasma protein-A level in IVF/ICSI pregnancies

Human Reproduction

Volumn 28, Issue 10, 2013, Pages 2636-2642

  Giorgetti, C ^a,b   Vanden Meerschaut, F ^c   De Roo, C ^c   Saunier, O ^a,b   Quarello, E ^a   Hairion, D ^a,b   Penaranda, G ^b   Chabert Orsini, V ^a   De Sutter, P ^c  

^a Medicine Institute of Reproduction   (France)

^b Laboratoire Alphabio   (France)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

assisted reproduction techniques; estradiol; first trimester aneuploidy screening; pregnancy associated plasma protein A

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRADIOL; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; PREGNANCY ASSOCIATED PLASMA PROTEIN A; RECOMBINANT FOLLITROPIN;

ADULT; ANEUPLOIDY; ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HORMONE BLOOD LEVEL; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; INTRAUTERINE INSEMINATION; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL SERUM; MATERNAL SERUM SCREENING TEST; NUCHAL TRANSLUCENCY MEASUREMENT; NUCHAL TRANSLUCENCY THICKNESS; OVULATION INDUCTION; PARAMETERS CONCERNING THE FETUS, NEWBORN AND PREGNANCY; PREDICTIVE VALUE; PRENATAL SCREENING; PROTEIN BLOOD LEVEL; REFERENCE VALUE; RETROSPECTIVE STUDY;

ASSISTED REPRODUCTION TECHNIQUES; ESTRADIOL; FIRST TRIMESTER ANEUPLOIDY SCREENING; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A;

ANEUPLOIDY; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMOSOME DISORDERS; ESTRADIOL; FALSE POSITIVE REACTIONS; FEMALE; FERTILIZATION IN VITRO; HUMANS; MULTIVARIATE ANALYSIS; NUCHAL TRANSLUCENCY MEASUREMENT; OVULATION; OVULATION INDUCTION; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; RETROSPECTIVE STUDIES;

EID: 84885151255     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/det295     Document Type: Article

References (26)

1. Amor DJ, Xu JX, Halliday JL, Francis I, Healy DL, Breheny S, Baker HW, Jaques AM. Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome. Hum Reprod 2009; 24:1330-1338.
2. Anckaert E, Schiettecatte J, Sleurs E, Devroey P, Smitz J. First trimester screening for Down's syndrome after assisted reproductive technology: Non-male factor infertility is associated with elevated free beta-human chorionic gonadotropin levels at 10-14 weeks of gestation. Fertil Steril 2008;90:1206-1210.
3. Bender F, Hecken J, Reinsberg J, Berg C, van der Ven H, Gembruch U, Geipel A. Altered first-trimester screening markers after IVF/ICSI: No relationship with small-for-gestational-age and number of embryos transferred. Reprod Biomed Online 2010;20:516-522.
4. Bersinger NA, Wunder D, Vanderlick F, Chanson A, Pescia G, Janecek P, Boillat E, Birkhaüuser MH. Maternal serum levels of placental proteins after in vitro fertilization and their implications for prenatal screening. Prenat Diagn 2004;24:471-477.
5. Billiar RB, Pepe GJ, Albrecht ED. Immunocytochemical identification of the oestrogen receptor in the nuclei of cultured human placental syncytiotrophoblasts. Placenta 1997;18:365-370.
6. Bukovky A, Cekanova L, Caudle MR, Wimalasena J, Foster JS, Henley DC. Expression and localization of estrogen receptor-alpha protein in normal and abnormal term placentae and stimulation of trophoblast differentiation by estradiol. Reprod Biol Endocrinol 2003;1:13.
7. Chen JZ, WongMH, Brennecke SP, Keogh RJ. The effects of human chorionic gonadotrophin, progesterone and oestradiol on trophoblast function. Mol Cell Endocrinol 2011;342:73-80.
8. de Graaf IM, Pajkrt E, Bilardo CM, Leschot NJ, Cuckle HS, van Lith JM. Early pregnancy screening for fetal aneuploidy with serum markers and nuchal translucency. Prenat Diagn 1999;19:458-462.
9. Engels MA, Kooij M, Schats R, Twisk JW, Blankenstein MA, van Vugt JM. First-trimester serum marker distribution in singleton pregnancies conceived with assisted reproduction. Prenat Diagn 2010;30:372-377.
10. Ghisoni L, Ferrazzi E, Castagna C, Levi Setti PE, Masini AC, Pigni A. Prenatal diagnosis after ART success: The role of early combined screening tests in counselling pregnant patients. Placenta 2003;24:S99-S103.
11. Giorgetti C, Terriou P, Auquier P, Hans E, Spach JL, Salzmann J, Roulier R. Embryo score to predict implantation after in-vitro fertilization: Based on 957 single embryo transfers. Hum Reprod 1995;10:2427-2431.
12. Giudice LC, Conover CA, Bale L, Faessen H, Ilg K, Sun I. Identifications and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: Evidence for paracrine regulation of IGF-II bioavailabiity in the placental bed during human implantation. J Clin Endocrinol Metab 2002;87:2359-2366.
13. Gjerris AC, Loft A, Pinborg A, Christiansen M, Tabor A. First-trimester screening markers are altered in pregnancies conceived after IVF/ICSI. Ultrasound Obstet Gynecol 2009a;33:8-17.
14. Gjerris AC, Loft A, Pinborg A, Christiansen M, Tabor A. The effect of a 'vanishing twin' on biochemical and ultrasound first trimester screening markers for Down's syndrome in pregnancies conceived by assisted reproductive technology. Hum Reprod 2009b;24:55-62.
15. Hui PW, Lam YH, Tang MH, NG EH, Yeung WS, Ho PC. Maternal serum pregnancy-associated plasma protein-A and free beta-human chorionic gonadotrophin in pregnancies conceived with fresh and frozen-thawed embryos from in vitro fertilization and intracytoplasmic sperm injection. Prenat Diagn 2005a;25:390-393.
16. Hui PW, Tang MH, Lam YH, Yeung WS, Ng EH, Ho PC. Nuchal translucency in pregnancies conceived after assisted reproduction technology. Ultrasound Obstet Gynecol 2005b;25:234-238.
17. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: Impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 2008;31:493-502.
18. Liao AW, Heath V, Kametas N, Spencer K, Nicolaides KH. First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod 2001;16:1501-1504.
19. Matilainen M, Peuhkurinen S, Laitinen P, Jarvela I, Morin-Papunen L, Ryynanen M. In combined first-trimester Down syndrome screening, the false-positive rate is not higher in pregnancies conceived after assisted reproduction compared with spontaneous pregnancies. Fertil Steril 2011; 95:378-381.
20. Maymon R, Shulman A. Integrated first- and second-trimester Down syndrome screening test among unaffected IVF pregnancies. Prenat Diagn 2004;24:125-129.
21. Nicolaides KH. Screening for foetal aneuploidies at 11 to 13 weeks. Prenat Diagn 2011;31:7-15.
22. Reinsberg J, Batz O, Bertsch T, Bewarder N, Deschner W, Drescher V. Precision and long-term stability of different estradiol immunoassays assessed in amulti-center quality control study. Clin Lab 2009;55:201-206.
23. Skakkebaek NE, Jørgensen N, Main KM, Rajpert-De Meyts E, Leffers H, Andersson AM, Juul A, Carlsen E, Mortensen GK, Jensen TK et al. Is human fecundity declining?. Int J Andrologia 2006;29:2-11.
24. Spencer K. The influence of smoking on maternal serum AFP and free beta hCG levels and the impact on screening for Down syndrome. Prenat Diagn 1998;18:225-234.
25. Spencer K, Ong CY, Liao AW, Nicoloiüdes KH. The influence of ethnic origin on first trimester biochemical markers of chromosomal abnormalities. Prenat Diagn 2000;20:491-494.
26. Tul N, Novak-Antolic Z. Serum PAPP-A levels at 10-14 weeks of gestation are altered in women after assisted conception. Prenat Diagn 2006; 26:1206-1211.